Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: Primary results from the phase IIIb TOURMALINE study
- DOI
- 10.1016/j.jhep.2026.06.025
- Published
- 2026-07
- Container
- Journal of Hepatology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jhep.2026.06.025,
title = {Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: Primary results from the phase IIIb TOURMALINE study},
author = {Do-Youn Oh and Masafumi Ikeda and Teresa Macarulla and Aiwu Ruth He and Joon Oh Park and Masayuki Kitano and Guido Giordano and Kyu-pyo Kim and Thomas Wirth and David Tai and Mohamed Bouattour and Tiziana Pressiani and Farshid Dayyani and Angela Lamarca and Ugochinyere Emeribe and Susanne Radke and Peng Sun and Boris Baur and Arndt Vogel},
year = {2026},
journal = {Journal of Hepatology},
doi = {10.1016/j.jhep.2026.06.025},
url = {https://doi.org/10.1016/j.jhep.2026.06.025}
}RIS
TY - JOUR TI - Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: Primary results from the phase IIIb TOURMALINE study AU - Do-Youn Oh AU - Masafumi Ikeda AU - Teresa Macarulla AU - Aiwu Ruth He AU - Joon Oh Park AU - Masayuki Kitano AU - Guido Giordano AU - Kyu-pyo Kim AU - Thomas Wirth AU - David Tai AU - Mohamed Bouattour AU - Tiziana Pressiani AU - Farshid Dayyani AU - Angela Lamarca AU - Ugochinyere Emeribe AU - Susanne Radke AU - Peng Sun AU - Boris Baur AU - Arndt Vogel PY - 2026 JO - Journal of Hepatology DO - 10.1016/j.jhep.2026.06.025 UR - https://doi.org/10.1016/j.jhep.2026.06.025 ER -
APA
Oh, D., Ikeda, M., Macarulla, T., He, A. R., Park, J. O., Kitano, M., Giordano, G., Kim, K., Wirth, T., Tai, D., Bouattour, M., Pressiani, T., Dayyani, F., Lamarca, A., Emeribe, U., Radke, S., Sun, P., Baur, B., & Vogel, A. (2026). Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: Primary results from the phase IIIb TOURMALINE study. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2026.06.025
Source records
- crossref · retrieved 2026-09-26T17:08:28.986Z